GSK PLC/ GB00BN7SWP63 /
2024-07-26 5:35:15 PM | Chg. +27.50 | Volume | Bid5:35:15 PM | Ask5:40:48 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
1,555.00GBX | +1.80% | 847,357 Turnover(GBP): 13.08 mill. |
-Bid Size: - | -Ask Size: - | 62.54 bill.GBP | - | - |
GlobeNewswire
07-01
Vera Therapeutics Announces Appointment of Industry Veteran David L. Johnson as Chief Operating Offi...
GlobeNewswire
06-20
Pancreatic Cancer Market Is Projecting to Expand As NCI-Funded Research Expects to Empower Market Gr...
GlobeNewswire
06-17
iTeos and GSK Initiate GALAXIES Lung-301 Phase 3 Study, Assessing Belrestotug and Dostarlimab in Pre...
GlobeNewswire
06-14
LIXTE Biotechnology Holdings announces collaboration on a New Colon Cancer Clinical Trial
GlobeNewswire
06-14
LIXTE Biotechnology Holdings to Collaborate with Roche and Netherlands Cancer Institute in New Colon...
GlobeNewswire
06-13
Anima Biotech to Present at the Society for Medicines Research’s Modulating RNA with Oligonucleotide...
GlobeNewswire
06-11
Myriad Genetics Collaborates with GSK to Improve Access to HRD Testing in 9 Countries
GlobeNewswire
06-10
RenovoRx Appoints Ryan Witt as Senior Vice President, Head of Corporate Strategy and Partnerships
GlobeNewswire
06-04
Nordicus Partners Corporation Appoints Peter Severin as Chairman Of The Board of Directors
GlobeNewswire
06-03
Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
05-30
SERB Pharmaceuticals appoints Vanessa Wolfeler as CEO to drive next stage of the company’s growth
GlobeNewswire
05-23
Ivy Brain Tumor Center announces Phase 0/2 clinical readout of niraparib indicating significant impr...